Adenosine receptors and Parkinson's disease
by
 
Kase, Hiroshi.

Title
Adenosine receptors and Parkinson's disease

Author
Kase, Hiroshi.

ISBN
9780124004054
 
9781435605138
 
9780080525952
 
9781281053831
 
9786611053833

Publication Information
San Diego, CA : Academic Press, ©2000.

Physical Description
1 online resource (xviii, 275 pages [1] color plate) : illustrations

Series
Pure and applied mathematics series ; v. 90
 
Pure and applied mathematics (Academic Press) ; 60.

Contents
Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. / Localisation of Adenosine Receptors in Brain and Periphery. / Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. / Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. / Biochemical Characterization of Adenosine Agonists and Antagonists. / Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. / The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. / Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. / Knockout Mice in the Study of Dopaminergic Diseases. / Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. / Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. / Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. / Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders.

Abstract
This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.

Subject Term
Parkinson's disease.
 
Adenosine -- Receptors.
 
Adenosine -- Antagonists -- Therapeutic use.
 
Parkinson Disease -- drug therapy. (DNLM)D010300Q000188
 
Purinergic P1 Receptor Antagonists. (DNLM)D058915
 
HEALTH & FITNESS -- Diseases -- Alzheimer's & Dementia.
 
MEDICAL -- Neurology.
 
Adenosine -- Receptors. (OCoLC)fst00796565
 
Parkinson's disease. (OCoLC)fst01053693

Genre
Electronic books.

Added Author
Kase, Hiroshi.
 
Richardson, Peter J.
 
Jenner, Peter, 1946-

Electronic Access
Available from ScienceDirect. Online version available for university members only. This requires an institutional login off-campus
 
ScienceDirect https://www.sciencedirect.com/science/book/9780124004054


Shelf NumberItem BarcodeShelf LocationShelf LocationHolding Information
RC382 .A34 2000 EB1187075-1001Elsevier E-Book CollectionsElsevier E-Book Collections